Concentra Group Holdings Parent, Inc.
Close on Oct 19, 2026
- Market cap
- $4.88B
- P/E (TTM)
- 24.8
- Dividend yield
- 0.65%
Earnings
Next report expected Nov 5, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | During market hours | $606.00M | $0.51 | $0.52 |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | During market hours | $569.60M | $0.39 | $0.40 |
| Q4 FY2025 Ended Dec 31, 2025 | Jan 28, 2026 | During market hours | $539.10M | $0.27 | $0.28 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | During market hours | $572.80M | $0.38 | $0.39 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | During market hours | $550.80M | $0.35 | $0.37 |
| Q1 FY2025 Ended Mar 31, 2025 | May 7, 2025 | During market hours | $500.80M | $0.30 | $0.32 |
| Q4 FY2024 Ended Dec 31, 2024 | Jan 23, 2025 | During market hours | $465.00M | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 31, 2024 | During market hours | $489.60M | $0.37 | $0.37 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 1, 2024 | During market hours | – | – | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Capital expenditures | 2026 | $70.00M to $80.00M | Maintained |
| Adjusted EBITDAnon-GAAP | 2026 | $485.00M to $495.00M | Raised |
| Free Cash Flownon-GAAP | 2026 | $220.00M to $240.00M | Raised |
| Income from operationsGAAP | full year 2026 | $381.00M to $391.00M | New |
| Net income attributable to the CompanyGAAP | full year 2026 | $203.00M to $210.00M | New |
| Net incomeGAAP | full year 2026 | $210.00M to $217.00M | Raised |
| Net cash provided by operating activitiesGAAP | full year 2026 | $300.00M to $310.00M | Raised |
| Revenue | 2026 | $2.33B to $2.38B | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Concentra Group Holdings Parent filed with the SEC
Concentra Appoints Tanner Newton Chief Financial Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Concentra Group Holdings Parent, Inc. Announces Results
Results of operations · Executive or director change · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
©2026 Concentra Inc. All rights reserved. 2nd Quarter 2026 Results August 6, 2026
Results of operations · Executive or director change · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Concentra Group Holdings Parent, Inc. Announces Results
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
©2026 Concentra Inc. All rights reserved. 1st Quarter 2026 Results May 7, 2026
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Concentra Chief Medical Officer Dr. Anderson
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Concentra Group Holdings Parent, Inc. Announces Fourth Quarter and Year Ended 2025 Results
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
©2026 Concentra Inc. All rights reserved. 4th Quarter 2025 Results February 26, 2026
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Concentra Announces Preliminary 2025 Financial Results, Provides 2026 Financial Guidance, and Announces Q4 2025 Earnings Call Date
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
©2025 Concentra Inc. All rights reserved. Investor Presentation January 28, 2026 ▪ 4th Quarter and Year-End 2025 Preliminary Results ▪ 2026 Guidance
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
©2026 Concentra Inc. All rights reserved. Concentra Investor Book January 2026 Improving the health of America’s workforce, one patient at a time
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
©2025 Concentra Inc. All rights reserved. Concentra Investor Presentation J.P. Morgan Healthcare Conference January 2026
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Concentra Group Holdings Parent, Inc. Announces Results
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
©2025 Concentra Inc. All rights reserved. 3rd Quarter 2025 Results November 6, 2025
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Concentra Group Holdings Parent, Inc. Announces Results
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
©2025 Concentra Inc. All rights reserved. 2nd Quarter 2025 Results August 7, 2025
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
of Pivot Onsite Innovations Acquisition
Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
Concentra Group Holdings Parent, Inc. Announces Results
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
©2025 Concentra Inc. All rights reserved. 1st Quarter 2025 Results May 7, 2025
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
of Definitive Agreement to Acquire Pivot Onsite Innovations
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
©2024 Concentra Inc. All rights reserved.
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
Concentra Announces Fourth Quarter and Full Year 2024 Results and Closing of Nova Medical Centers Acquisition
Material agreement · Acquisition or disposition completed · Results of operations · New financial obligation · Other events · EX-99.1 to Form 8-K
©2024 Concentra Inc. All rights reserved. 4th Quarter and Year-End 2024 Results & Company Updates March 3, 2025
Material agreement · Acquisition or disposition completed · Results of operations · New financial obligation · Other events · EX-99.2 to Form 8-K
Concentra Announces Preliminary 2024 Financial
Material agreement · Results of operations · EX-99.1 to Form 8-K
©2024 Concentra Inc. All rights reserved. 4 th Quarter and Year - End 2024 Preliminary Results & Acquisition of Nova Medical Centers January 22, 2025 &
Material agreement · Results of operations · EX-99.2 to Form 8-K
©2024 Concentra Inc. All rights reserved.
Regulation FD disclosure · EX-99.1 to Form 8-K
Concentra Group Holdings Parent, Inc.
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
©2024 Concentra Inc. All rights reserved.
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Concentra Group Holdings Parent, Inc.
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
©2024 Concentra Inc. All rights reserved.
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K